Alteogen and Daiichi Sankyo Partner to Develop Subcutaneous ENHERTU® Using Novel Hyaluronidase Technology

Alteogen Inc. (KOSDAQ:196170) announced that the company has entered into an exclusive license agreement with Daiichi Sankyo (TSE: 4568). Under the terms o...

November 11, 2024 | Monday | News
AstraZeneca to Create Over 800 Skilled Jobs in Asia with $1.5B ADC Manufacturing Facility in Singapore

AstraZeneca plans to hire over 800 employees in Singapore for highly skilled roles ranging from engineering, quality, technical services to global supply c...

November 07, 2024 | Thursday | News
Duoning Biotechnology and Branca Bunús Form Strategic Alliance to Enhance Transfection Reagents for Biopharma Innovation

Duoning Biotechnology Group ("Duoning") announced a strategic partnership agreement with Branca Bunús Ltd. ("Branca Bunús"). Under this agree...

November 06, 2024 | Wednesday | News
Ring Therapeutics Strengthens Partnerships with Singapore’s A*STAR and SERI to Advance Gene Therapy for Eye Diseases and Cancer

Ring Therapeutics, a pioneering life sciences company under Flagship Pioneering dedicated to reshaping gene therapy through its unique commensal virome p...

November 05, 2024 | Tuesday | News
BioCity Biopharma Unveils Positive Late-Breaking Results from 2-SUCCEED Trial of SC0062 for IgA Nephropathy at ASN Kidney Week 2024

BioCity Biopharma (BioCity) announced late-breaking results of the 2-SUCCEED clinical trial of SC0062, a selective endothelin receptor type A (ETA) an...

November 05, 2024 | Tuesday | News
GSK Acquires CMG1A46 from Chimagen for $300 Million to Target B Cell-Driven Autoimmune Diseases

GSK plc (LSE/NYSE: GSK) and Chimagen Biosciences (Chimagen), a privately held biotechnology company, announced an agreement for GSK to acquire CMG1A46, a c...

October 30, 2024 | Wednesday | News
Taiwan’s Bora Pharmaceuticals Expands Rare Disease Portfolio with Acquisition of U.S.-Based Pyros Pharmaceuticals

Bora Pharmaceuticals Co., Ltd. ("Bora" or "the Company", TWSE: 6472),  announced that its Board of Directors has approved the acquisition of US-based ...

October 28, 2024 | Monday | News
PacBio Partners with Singapore’s National Cancer Centre to Advance Cancer Research in Asia

PacBio , a leading developer of high-quality, highly accurate sequencing solutions,  announced the signing of a new Research Collaboration Agre...

October 14, 2024 | Monday | News
Dizal Secures Breakthrough Therapy Designation for Sunvozertinib in Advanced NSCLC Treatment

Dizal (, a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced that th...

October 14, 2024 | Monday | News
Burning Rock and Dizal Announce First NGS-Based Lung Cancer Diagnostic Approval by China’s NMPA

Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), an innovative company in the field of precision onco...

October 11, 2024 | Friday | News
Basilea Pharmaceutica Secures $1.25 Million Milestone Payment Following Strong Sales of Cresemba® in Asia Pacific and China

Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and ...

October 10, 2024 | Thursday | News
Dräger India Launches BabyRoo® TN 300, Transforming Newborn Care with Advanced Thermoregulation and Family-Centered Technologies

Dräger India is proud to announce the launch of the BabyRoo® TN 300 open warmer, with state-of-the-art thermoregulation capabilities as well as ad...

October 10, 2024 | Thursday | News
Roche Survey Reveals Half of Global Respondents Unaware of HPV’s Link to Cervical Cancer, Urging Immediate Action

Survey findings from over 8,700 people in 12 countries show that half of those polled have inadequate understanding of HPV, with ne...

October 08, 2024 | Tuesday | Reports
NovaCina Expands Perth Facility with Advanced SA25 GMP Filling Line to Enhance Global CDMO Services

NovaCina, a global contract development and manufacturing organization (CDMO), has today announced the expansion of its facility in Perth, Australia with...

October 08, 2024 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close